Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase.
An amphipathic alpha-helical decapeptide in phosphatidylcholine is an effective synthetic lung surfactant.
- L. McLean, J. Lewis, M. H. Payne
- Chemistry, BiologyThe American review of respiratory disease
- 1 February 1993
The data demonstrate that a small water-soluble synthetic peptide containing an amphipathic alpha-helical structure combined solely with the major lipid of natural lung surfactant is effective in restoring lung compliance and gas exchange in surfactants-deficient lungs and may be useful in treatment of the respiratory distress syndromes.
Centrally truncated and stabilized porcine neuropeptide Y analogs: design, synthesis, and mouse brain receptor binding.
- J. Krstenansky, T. J. Owen, S. H. Buck, K. Hagaman, L. McLean
- Biology, ChemistryProceedings of the National Academy of Sciences…
- 1 June 1989
It is proposed that the central region of pNPY serves a structural role in the peptide and is not involved in direct receptor interaction.
Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.
Minimal peptide length for interaction of amphipathic alpha-helical peptides with phosphatidylcholine liposomes.
The interactions of a series of amphipathic alpha-helical peptides containing from 6 to 18 amino acid residues with dipalmitoylphosphatidylcholine and DPPC were studied by optical and calorimetric methods and formed small micellar structures, as judged by gel filtration chromatography.
Short model peptides having a high α‐helical tendency: Design and solution properties
Interaction of hirudin with thrombin: identification of a minimal binding domain of hirudin that inhibits clotting activity.
It is shown that the carboxyl-terminal 10 amino acid residues 56-65 are minimally required for binding to thrombin and inhibition of clotting and associated with a significant conformational change of Thrombin as judged by circular dichroism.
Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin.
- J. Krstenansky, R. Broersma, T. J. Owen, M. H. Payne, M. T. Yates, S. Mao
- Biology, ChemistryThrombosis and haemostasis
- 12 April 1990
The development of MDL 28,050 and other effective antithrombin agents are outlined through the description of the structure-activity relationships (SAR) for these peptides, which are effective in a variety of in vitro and in vivo models of thrombosis.
Anticoagulant peptides: nature of the interaction of the C-terminal region of hirudin with a noncatalytic binding site on thrombin.
- J. Krstenansky, T. J. Owen, M. T. Yates, S. Mao
- Biology, ChemistryJournal of medicinal chemistry
- 1 September 1987
A "kinked" amphipathic alpha-helical structure, which orients all of the residues most critical for activity on one face of the helix, is proposed for anticoagulant activity in hirudin.